Preliminary proxy statements relating to merger or acquisition

Submission

v3.25.3
Submission
Nov. 28, 2025
Submission [Line Items]  
Central Index Key 0000882361
Registrant Name Aptose Biosciences Inc.
Form Type SC 14A
Submission Type PREM14A
Fee Exhibit Type EX-FILING FEES
Offering Table N/A
Offset Table N/A N/A